Journal: bioRxiv
Article Title: Early cell autonomous and niche-mediated alveolar epithelial response to influenza infection in primary lung organoids
doi: 10.1101/2025.10.24.684481
Figure Lengend Snippet: (A) Schematic of method for liberation and treatment of AEOs with IAV. (B-E) AEOs treated with H1N1 develop progressively increased influenza infection as measured by nuclear expression of H1N1 NP across 24hpi. (F) Quantification of NP-positive nuclei at each timepoint of infection. (G) Cell type specific infection in AEOs. Significantly more AT2 are infected than AT1 by 8hpi and thereafter. (H) Expression of the flu binding α-2,6-sialic acid in AEOs marked by expression of sambuccus nigra lectin predominantly in AT2 cells. (I-J). In vivo confirmation of SNA expression (I) and increased infection rate (J) in AT2 cells during early flu. Scale bars = 50 μm. (SPC = Surfactant Protein C [AT2 marker]; Ager = Advance Glycosylation End-product Specific Receptor [AT1 marker]; NP = IAV nucleoprotein [infected cell marker], SNA = Sambuccus nigra lectin [flu binding motif α-2,6-sialic acid]) . P values by ANOVA with multiple comparison (F,G,J) or T test (I): * = <0.05, ** = <0.01, *** = < 0.001, **** = < 0.0001.
Article Snippet: Human AT2s were plated as described above for murine AT2 except MRC5s (ATCC CCL-171, tested negative for mycobacterial contamination) at P8 were used as a replacement for the murine fibroblast stock.
Techniques: Infection, Expressing, Binding Assay, In Vivo, Marker, Glycoproteomics, Comparison